|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Epilepsy Adv Seq and CNV Eval-Encephalopathy
Test Code94555
CPT Codes
81302, 81403, 81404 (x3), 81405 (x4), 81406 (x4), 81407, 81479<br /> Limited Access Code
Physician Attestation of Informed Consent
This germline genetic test requires physician attestation that patient consent has been received if ordering medical facility is located in AK, DE, FL, GA, IA, MA, MN, NV, NJ, NY, OR, SD or VT or test is performed in MA.
Includes
ARHGEF9, ARX, CDKL5, CNTNAP2, FOXG1, GABRG2, GRIN2A, KCNT1, MECP2, NRXN1, PCDH19, PNKP, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, SCN1A, SCN1B, SCN2A, SCN8A, SCN9A, SLC25A22, SLC2A1, SLC9A6, SPTAN1, STXBP1, SYNGAP1, TCF4, TREX1, UBE3A, ZEB2, ADSL, ALG13, ALG9, AMT, BRAT1, CACNA2D1, CACNA2D2, CHD2, DNM1, DOCK7, EEF1A2, GLDC, GNAO1, GRIN1, GRIN2B, HCN1, HNRNPU, KCNA2, KCNB1 , KCNJ11, LIAS, PIGA, PIGN, PLCB1, PNPO, PURA, QARS, SIK1, SLC13A5, SLC19A3, SLC25A19, SLC35A2, ST3GAL5, SZT2, WDR45, WWO
Preferred Specimen
8 mL whole blood in each of two EDTA (lavender-top) tubes, or
Pediatric (0-3 years): 2 mL whole blood
Pediatric (0-3 years): 2 mL whole blood
Minimum Volume
6 mL • 1 mL pediatric whole blood
Instructions
Please label each specimen tube with two forms of patient identification. These forms of identification must also appear on the requisition form.
Higher blood volumes ensure adequate DNA quantity, which varies with WBC, specimen condition, and need for confirmatory testing. Patients, 0-3 years have higher WBC, yielding more DNA per mL of blood.
Higher blood volumes ensure adequate DNA quantity, which varies with WBC, specimen condition, and need for confirmatory testing. Patients, 0-3 years have higher WBC, yielding more DNA per mL of blood.
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 10 days
Refrigerated: 10 days
Frozen: Unacceptable
Methodology
Next Generation Sequencing • CNV Analys using NGS • Targeted Microarray
Setup Schedule
Set up: As needed; Report available: 28-35 days
Reference Range
See Laboratory Report
Clinical Significance
This diagnostic panel detects DNA sequence variants and copy number variations (CNV) in genes that are associated with genetic forms of epileptic encephalopathy (EE). EEs are electroclinical syndromes associated with a high probability of encephalopathic features that present or worsen after the onset of epilepsy. As a group EEs tend to be pharmacoresistant, regressive, severe in infancy and early childhood, and associated with profound cognitive impairment.